UPDATED Apr 25, 2024
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
2330 | NT$766.00 | 2.1% | 52.6% | NT$19.9t | NT$912.98 | PE23.2x | E16.1% | 1.8% | Semiconductors | ||
AZN | UK£120.26 | 10.2% | 1.9% | UK£186.4b | UK£128.74 | PE36.8x | E16.5% | 1.9% | Pharmaceuticals & Biotech | ||
NOVN | CHF90.00 | 6.5% | -1.5% | CHF183.6b | CHF98.74 | PE22.1x | E10.0% | 3.7% | Pharmaceuticals & Biotech | ||
ROG | CHF218.80 | -0.5% | -20.8% | CHF176.4b | CHF279.39 | PE15.2x | E8.6% | 4.4% | Pharmaceuticals & Biotech | ||
AIR | €158.52 | -1.3% | 26.3% | €124.8b | €175.38 | PE32.9x | E17.6% | 1.1% | Capital Goods | ||
SAF | €207.50 | -0.3% | 48.1% | €85.8b | €206.26 | PE24.9x | E5.8% | 1.1% | Capital Goods | ||
SLB | US$49.44 | -2.9% | 3.1% | US$70.7b | US$67.11 | PE16.3x | E13.1% | 2.2% | Energy | ||
ZURN | CHF442.60 | -0.09% | 4.1% | CHF63.7b | CHF459.26 | PE16.1x | E8.6% | 5.9% | Insurance | ||
NTES | US$94.12 | 1.8% | 6.3% | US$60.7b | US$132.85 | PE14.9x | E7.9% | 2.7% | Media | ||
BBRI | Rp5,150.00 | -2.4% | 1.0% | Rp776.6t | Rp6,591.96 | PB2.7x | E12.1% | 6.2% | Banks | ||
2454 | NT$981.00 | -1.2% | 47.5% | NT$1.6t | NT$1,199.29 | PE20.3x | E14.0% | 6.2% | Semiconductors | ||
BMRI | Rp6,950.00 | 3.3% | 34.3% | Rp648.7t | Rp7,544.68 | PB2.5x | E9.4% | 5.1% | Banks | ||
2020 | HK$90.00 | 7.4% | -7.0% | HK$252.1b | HK$111.78 | PE23.1x | E13.0% | 2.5% | Consumer Durables | ||
EVO | kr1,244.50 | -3.9% | -11.1% | kr262.6b | kr1,488.44 | PE20.7x | E12.4% | 2.5% | Consumer Services | ||
300274 | CN¥99.27 | 4.3% | -11.9% | CN¥142.3b | CN¥131.17 | PE14.5x | E10.8% | 1.0% | Capital Goods | ||
ALL | AU$40.20 | -0.3% | 6.0% | AU$26.0b | AU$47.49 | PE17.5x | E5.1% | 1.7% | Consumer Services | ||
KCHOL | ₺213.40 | -0.5% | 169.3% | ₺541.2b | ₺215.07 | PE7.5x | E26.5% | 3.7% | Capital Goods | ||
SOON | CHF251.70 | 1.2% | -9.9% | CHF15.0b | CHF270.88 | PE25x | E10.7% | 1.8% | Healthcare | ||
300015 | CN¥12.63 | 4.0% | -44.3% | CN¥114.2b | CN¥22.13 | PE33.9x | E21.8% | 0.6% | Healthcare | ||
2027 | CN¥6.85 | -1.4% | 6.4% | CN¥101.0b | CN¥8.02 | PE23.2x | E19.0% | 6.1% | Media | ||
JMT | €18.63 | 4.0% | -17.6% | €11.7b | €23.39 | PE15.5x | E6.7% | 3.5% | Consumer Retailing | ||
HTHT | US$39.74 | 6.4% | -12.8% | US$12.5b | US$52.39 | PE22.1x | E10.7% | 3.1% | Consumer Services | ||
300122 | CN¥34.83 | -14.0% | -35.8% | CN¥81.9b | CN¥62.47 | PE11.1x | E23.8% | 2.3% | Pharmaceuticals & Biotech | ||
600845 | CN¥39.77 | 6.1% | -11.6% | CN¥80.7b | CN¥49.57 | PE36.1x | E21.2% | 2.5% | Software |